(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

PRESCIENT

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

PRESCIENT

ST13

US500000079332278

Classe

9, 35, 42

Pedido

79332278

Registro

7141214

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

36

Atualização mais recente

20/02/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

9, 35, 42

Data de depósito

15/09/2021

Data de registro

22/08/2023

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

22/08/2023

Última transação

20/02/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

99

Localização do titular

GB

Examinador

BROWN, TINA

Unidade examinadora

M90

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

Prescient Healthcare Group Limited

Representantes

Patrick C. Stephenson Kutak Rock LLP

Classificação técnica

Classes Nice

Classe 9Classe 35Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 9

Downloadable computer software for business purposes for use in database management; Downloadable software for the analysis of business data; Downloadable software for use in relation to brand strategy for data analysis and situational analysis; Downloadable application software for the provision of scientificpharmaceutical and biotechnological newsinformationresearch; downloadable software platforms for business assistance and information for data managementanalysing business dataaccessing business informationprocessing business data; downloadable software platforms for database management; downloadable software platforms to enable businesses to developvisualisedownload business and scientific analyses; downloadable cloud based software platforms for database management; downloadable cloud based software platforms for enabling businesses to developvisualisedownload business analyses in the scientifichealthcarepharmaceuticalbiotechnology and biopharmaceuticals industries; downloadable application software and software platforms for providing business and technical informationadviceresearch for use in relation to the scientifichealthcarepharmaceuticalbiotechnology and biopharmaceuticals industries; downloadable artificial intelligence software for synchronizing data between a central database and other databases; downloadable cloud-based electronic databasescomputer databases and interactive databases featuring information in the scientifichealthcarepharmaceuticalbiotechnology and biopharmaceuticals fields; downloadable digital materialsreportsnews alerts and newsletters in relation to the scientifichealthcarepharmaceuticalbiotechnology and biopharmaceuticals sectors; downloadable cloud-based interactive databases in the field of sciencehealthcarepharmaceuticalsbiotechnologybiopharmaceuticals

Classe 35

Competitive intelligence services; business planning services; strategic business analysis; expert evaluations and reports relating to commercial and business matters; business data analysis; advice and information concerning commercial business management and strategy; advisory services relating to market research; analysis of market research data and statistics; market assessment consultancy; market assessment services; informationadvisory and consultancy services in relation to all of the aforesaid services

Classe 42

Software as a service (SaaS) services featuring software for database managementfor use by others to analyze market research information and intelligence in relation to the scientifichealthcarepharmaceuticalbiotechnology and biopharmaceuticals sectors; software as a service (SaaS) service featuring artificial intelligence software for synchronizing data between a central database and other databases; design and development of computer software for use in relation to the scientifichealthcarepharmaceuticalbiotechnology and biopharmaceutical industries; scientific analysis of pharmaceuticals and biopharmaceuticals; biological analysis; biochemical analysis; technological analysis servicespharmaceutical product profiling analysis and clinical data analysis; scientific and technical advice and consultancy services in relation to scientifichealthcarepharmaceuticalbiotechnology and biopharmaceuticals industriesscientific research advice and consultancypharmaceutical products development advice and consultancypharmaceutical research and development advice and consultancy; developmentdesign and testing of pharmaceuticalbiotechnology and biopharmaceutical products; encryptiondecryption and authentication of informationmessages and data; data encryption services; development of computer database software in relation to the pharmaceuticalbiotechnology and biopharmaceutical industries; installationmaintenance and updating of database software in relation to the pharmaceuticalbiotechnology and biopharmaceutical industries; providing onlinenon-downloadable software for use in database managementfor use by others to analyze market research information and intelligence in relation to the scientifichealthcarepharmaceuticalbiotechnology and biopharmaceuticals sectors; providing onlinenon-downloadable software for database management in relation to the pharmaceuticalbiotechnology and biopharmaceutical industries; biological researchclinical research in the nature of determining the safety and effectiveness of pharmaceuticalsmedicationsmedical devicesdiagnostic products and treatment regimens and medical research

Publicações

Histórico de despachos e eventos da marca no USPTO.

36 publicações encontradas

NREP

NEW REPRESENTATIVE AT IB RECEIVED

19/02/2026

NREP

NEW REPRESENTATIVE AT IB RECEIVED

05/02/2026

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

11/12/2023

FICS

FINAL DISPOSITION NOTICE SENT TO IB

22/11/2023

FIMP

FINAL DISPOSITION PROCESSED

22/11/2023

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

22/11/2023

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

22/08/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

22/08/2023

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

25/07/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

05/07/2023

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

05/07/2023

GPNX

NOTIFICATION PROCESSED BY IB

06/06/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/06/2023

PUBO

PUBLISHED FOR OPPOSITION

06/06/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

17/05/2023

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

17/05/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

17/05/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/05/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/05/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/05/2023

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

01/05/2023

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

29/01/2023

GNFR

FINAL REFUSAL E-MAILED

29/01/2023

CNFR

FINAL REFUSAL WRITTEN

29/01/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

27/12/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

26/12/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

26/12/2022

RFNP

REFUSAL PROCESSED BY IB

19/07/2022

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

28/06/2022

RFRR

REFUSAL PROCESSED BY MPU

27/06/2022

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

24/06/2022

CNRT

NON-FINAL ACTION WRITTEN

23/06/2022

DOCK

ASSIGNED TO EXAMINER

19/06/2022

MAFR

APPLICATION FILING RECEIPT MAILED

08/02/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/02/2022

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

03/02/2022

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace PRESCIENT ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.